Efficacy of immunotherapy for metastatic mucosal melanoma

Immunotherapy. 2016 Jul;8(8):843-5. doi: 10.2217/imt-2016-0036.
No abstract available

Keywords: CTLA-4; PD1; PDL1; immunotherapy; melanoma.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Female
  • Humans
  • Ipilimumab / therapeutic use*
  • Male
  • Melanocytes / pathology*
  • Melanoma / immunology
  • Melanoma / pathology
  • Melanoma / therapy*
  • Mucous Membrane / pathology*
  • Neoplasm Metastasis
  • Nose Neoplasms / immunology
  • Nose Neoplasms / pathology
  • Nose Neoplasms / therapy*
  • Programmed Cell Death 1 Receptor / immunology
  • Skin Neoplasms / immunology
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Ipilimumab
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor